Prothena Corporation plc today announced the Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients with AL amyloidosis did not meet its primary endpoint (HR=0.915, p-value=0.7680). Based ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Affirm Holdings. Looking at options history for Affirm Holdings AFRM we detected 12 trades. If we consider the specifics ...

Rating for Affirm Holdings Cl A climbed into a new percentile Friday, with an increase from 69 to 80. Please watch the video ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

Pagaya Technologies, the AI-powered consumer-lending firm, is issuing its first bond backed by loans made to online shoppers, ...

Mastercard and Affirm, though both in the digital payments arena, represent opposite ends of the spectrum—one a legacy ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Mastercard and Affirm are battling from opposite corners of the digital payments ring: one a legacy juggernaut, the other a fintech disruptor. Mastercard dominates with global infrastructure and ...

(Justin Sullivan/Getty Images) ↗️ Microchip Technology(MCHP): The chips and circuits maker's stock jumped over 10% after it raised its sales forecast and said that the chip industry has hit ...

The jury’s verdict in this case is not excessive simply because it is in the amount of $725M,” Jacquinto wrote in response to ...

We recently compiled a list of the Traders Flee These 10 Stocks Today. In this article, we are going to take a look at where ...